Immunomodulation of RA Patients’ PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens - Université Toulouse III - Paul Sabatier - Toulouse INP Accéder directement au contenu
Article Dans Une Revue Mediators of Inflammation Année : 2017

Immunomodulation of RA Patients’ PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens

Résumé

Citrullinated peptides are used for measuring anticitrullinated protein antibodies (ACPA) in rheumatoid arthritis (RA). Accumulation of citrullinated proteins in the inflamed synovium suggests that they may be good targets for inducing peripheral tolerance. In view of the multiplicity of citrullinated autoantigens described as ACPA targets, we generated a multiepitope citrullinated peptide (Cit-ME) from the sequences of major citrullinated autoantigens: filaggrin, β -fibrinogen, vimentin, and collagen type II. We assessed the ability of Cit-ME or the citrullinated β 60-74 fibrinogen peptide ( β 60-74-Fib-Cit) which bears immunodominant citrullinated epitopes (i) to modify cytokine gene expression and (ii) to modulate Treg and Th17 subsets in PBMC derived from newly diagnosed untreated RA patients. RA patient’s PBMC incubated with Cit-ME or β 60-74-Fib-Cit, showed upregulation of TGF- β expression (16% and 8%, resp.), and increased CD4 + Foxp3 + Treg (22% and 19%, resp.). Both peptides were shown to downregulate the TNF- α and IL-1 β expression; in addition, Cit-ME reduced CD3 + IL17 + T cells. We showed that citrullinated peptides can modulate the expression of anti- and proinflammatory cytokines in PBMC from RA patients as well as the proportions of Treg and Th17 cells. These results indicate that citrullinated peptides could be active in vivo and therefore might be used as immunoregulatory agents in RA patients.
Fichier principal
Vignette du fichier
Gertel_2017.pdf (1.56 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03368955 , version 1 (07-10-2021)

Identifiants

Citer

Smadar Gertel, Gidi Karmon, Sivan Vainer, Ora Shovman, Martin Cornillet, et al.. Immunomodulation of RA Patients’ PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens. Mediators of Inflammation, 2017, 2017, 9 p. ⟨10.1155/2017/3916519⟩. ⟨hal-03368955⟩
16 Consultations
20 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More